Showing results (1851-1860 of 1,875) with videos related to
Sort By:
Pageof 188
Burns : Journal of the International Society for Burn Injuries|September 30, 2023
Patterns of antibiotic administration in patients with burn injuries: A TriNetX studyKendall Wermine, Sunny Gotewal, Juquan Song, et al.Journal of Burn Care & Research : Official Publication of the American Burn Association|May 18, 2018
Burn Surgeon and Palliative Care Physician Attitudes Regarding Goals of Care Delineation for Burned Geriatric PatientsHolly B Cunningham, Shannon A Scielzo, Paul A Nakonezny, et al.Journal of Burn Care & Research : Official Publication of the American Burn Association|June 23, 2018
Renal Replacement Therapy in Severe Burns: A Multicenter Observational StudyKevin K Chung, Elsa C Coates, William L Hickerson, et al.Neurological Research and Practice|February 11, 2025
Association of oral anticoagulants with risk of brain haemorrhage expansion compared to no-anticoagulationRoland Veltkamp, Kirsten Haas, Viktoria Rücker, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 21, 2017
Thalamic deep brain stimulation for orthostatic tremor: A multicenter international registryAristide Merola, Alfonso Fasano, Anhar Hassan, et al.Scandinavian Journal of Rheumatology|January 1, 1996
Tenidap in patients with rheumatoid arthritis. A 4-week, placebo-controlled studyH M Prupas, L D Loose, J S Spindler, et al.Environmental Health Perspectives|March 26, 2013
Linking geological and health sciences to assess childhood lead poisoning from artisanal gold mining in NigeriaGeoffrey S Plumlee, James T Durant, Suzette A Morman, et al.Journal of Burn Care & Research : Official Publication of the American Burn Association|April 5, 2008
A clarion to recommit and reaffirm burn rehabilitationReginald L Richard, Travis L Hedman, Charles D Quick, et al.American Journal of Medical Genetics. Part A|April 9, 2009
Pathogenic FBN1 mutations in 146 adults not meeting clinical diagnostic criteria for Marfan syndrome: further delineation of type 1 fibrillinopathies and focus on patients with an isolated major criterionL Faivre, G Collod-Beroud, B Callewaert, et al.European Journal of Human Genetics : EJHG|November 13, 2008
Clinical and mutation-type analysis from an international series of 198 probands with a pathogenic FBN1 exons 24-32 mutationL Faivre, G Collod-Beroud, B Callewaert, et al.Pageof 188